Related Experiment Video
Updated: Aug 5, 2026

08:45
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Fluconazole resistance in Candida glabrata
C A Hitchcock1, G W Pye, P F Troke
1Department of Discovery Biology, Pfizer Central Research, Sandwick, Kent, United Kingdom.
Antimicrobial Agents and Chemotherapy
|September 1, 1993
Summary
This study details a Candida glabrata infection that developed fluconazole resistance. Researchers found resistance stemmed from a drug permeability issue, not enzyme changes, impacting antifungal treatment strategies.
Area of Science:
- Medical Mycology
- Antifungal Drug Resistance
- Clinical Microbiology
Background:
- Candida glabrata is an opportunistic fungal pathogen causing infections, particularly in immunocompromised individuals.
- Azole antifungal agents, like fluconazole, are primary treatments for Candida infections.
- Emergence of antifungal resistance in Candida species poses a significant clinical challenge.
Related Concept Videos
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

